Clinical Study of Chimeric CD(Cluster of Differentiation)138 Antigen Receptor-modified T Cells in Relapsed and/or Chemotherapy Refractory Multiple Myelomas
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti CD138 CAR transduced T cells (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 28 Jan 2016 Biomarkers information updated
- 14 Aug 2013 New trial record